Enriqueta Felip

Interviews and expert commentary tagged “Enriqueta Felip” — the latest oncology research and clinical practice from the Audio Journal of Oncology.

Long Overall Survival in Ceritinib-Treated ALK-Positive Lung Cancer
Audio Journal of Oncology

Long Overall Survival in Ceritinib-Treated ALK-Positive Lung Cancer

MUNICH—More than four years median overall survival was reported in patients treated with an inhibitor of anaplastic lymphoma kinase (ALK) for their ALK gene rearranged non-small cell lung cancer (NSC

27 October 2018
7 minutes